That changes in July 2026, when the new Medicare GLP-1 Bridge program begins offering coverage at just $50 per month for eligible beneficiaries
Oral dosing expands the audience and pulls GLP-1s deeper into primary care, requiring marketers to engage not just endocrinologists and obesity specialists, but PCPs, cardiologists, hepatologists and payers
Food and Drug Administration (FDA), Wegovy is not just another diet aid
If someone is admitted for exacerbation of heart failure, theyre leaving the hospital with five medicines, all guideline-directed
These medications are safe to use with semaglutide and can bridge the adjustment period while your body adapts to the injection
Why are peptides getting so much press